Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
10(59%)
Results Posted
75%(3 trials)
Terminated
1(6%)

Phase Distribution

Ph phase_3
3
18%
Ph not_applicable
7
41%
Ph phase_2
4
24%

Phase Distribution

0

Early Stage

4

Mid Stage

3

Late Stage

Phase Distribution14 total trials
Phase 2Efficacy & side effects
4(28.6%)
Phase 3Large-scale testing
3(21.4%)
N/ANon-phased studies
7(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

10

trials recruiting

Total Trials

17

all time

Status Distribution
Active(11)
Completed(4)
Terminated(1)
Other(1)

Detailed Status

Recruiting9
Completed4
Active, not recruiting1
Not yet recruiting1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
10
Success Rate
80.0%
Most Advanced
Phase 3

Trials by Phase

Phase 24 (28.6%)
Phase 33 (21.4%)
N/A7 (50.0%)

Trials by Status

completed424%
active_not_recruiting16%
not_yet_recruiting16%
recruiting953%
terminated16%
unknown16%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT05871307Not Applicable

Neoadjuvant vs. Intraoperative vs. Adjuvant Resection Cavity Radiotherapy of Brain Metastases

Recruiting
NCT05357846Phase 3

PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)

Recruiting
NCT07071727Not Applicable

Short Course of Radiotherapy Prior to Surgery of Soft Tissue Sarcomas

Recruiting
NCT06739655Not Applicable

Preoperative Radiation Therapy and Immediate Breast Reconstruction

Recruiting
NCT04425967Not Applicable

Short Course Of Preoperative Radiotherapy in Head and Neck-, Trunk- and Extremity Soft Tissue Sarcomas

Active Not Recruiting
NCT07164872Not Applicable

Neoadjuvant Chemotherapy Combined With Preoperative Radiotherapy for Locally Advanced Breast Cancer

Not Yet Recruiting
NCT07026149Phase 2

Perioperative Treatment of Combined Radiotherapy With SOX, Apatinib and Camrelizumab for Oesophagogastric Cancer

Recruiting
NCT04261244Phase 3

NeoRad Breast Cancer Study

Recruiting
NCT06826885

Safety and Efficacy of IMPT or IMRT for Breast Cancer

Recruiting
NCT03822936Phase 2

Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma

Terminated
NCT05512286Not Applicable

Patient-Reported Outcome and Safety Between Preoperative and Postmastectomy Radiotherapy in DIEP Flap Reconstruction

Recruiting
NCT01216202

Sexual Function and Wellbeing in Males With Rectal Cancer

Completed
NCT01444495Not Applicable

Randomized Clinical Trial on Preoperative Radiotherapy 25 Gy in Rectal Cancer

Completed
NCT01216189

Sexual Function and Wellbeing in Females With Rectal Cancer

Completed
NCT04288999Phase 3

Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer

Recruiting
NCT02123381Phase 2

Changes in Tumor Tissue and Serum Biomarkers Before and After Cetuximab Combined With Preoperative Radiotherapy in Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Unknown
NCT00865189Phase 2

A Study of Bevacizumab (Avastin) in Participants With Newly Diagnosed Locally Advanced Rectal Cancer

Completed

All 17 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
17